London?s FTSE 100 pushed higher on Thursday, leaving peers on the continent and beyond in its wake, on share price rises for heavyweights AstraZeneca, Barclays and Unilever, as well as M&A impetus for Anglo American.Trade was underwhelming elsewhere, however, as equities struggled following a red-hot US inflation reading, which was coupled with numbers showing a slowdown in growth.The FTSE 100 ind

Stock prices were up in London heading into the afternoon on Thursday, with Anglo American leading the charge on confirming it was ?reviewing? a takeover bid from its larger Australian rival BHP Group.The FTSE 100 index was up 54.22 points, 0.7%, at 8,094.60. The FTSE 250 was down 20.05 points, 0.1%, at 19,699.32, and the AIM All-Share was up 0.33 of a point at 755.02.The Cboe UK 100 was up 0.7% a

First quarter sales and profit beat expectationsStrategy update scheduled for 21 MayFull year outlook confirmedShares in AstraZeneca (AZN) surged 5% to £119.3 closing in on a new 52-week high after first quarter revenue and earnings eclipsed market expectations and the pharmaceutical company reiterated full year guidance.After a few months of consolidation, the shares are back to winning ways and

Investors in London bought at the open on Thursday, looking ahead to US GDP data this afternoon, while Anglo American shares jumped after it confirmed that it was ?reviewing? a takeover bid from its larger Australian rival BHP Group.The FTSE 100 index opened up 33.81 points, 0.4%, at 8,074.19. The FTSE 250 was down 98.85 points, 0.5%, at 19,620.52, and the AIM All-Share was down 0.60 of a point, 0

Stocks in London ended in the red on Wednesday, despite the FTSE 100 hitting another record high earlier in the day, while Tesla was the star in New York, where wider markets mixed.The FTSE 100 index gave back 4.43 points, 0.1%, at 8,040.38. The blue-chip index traded as high as 8,092.19 earlier Wednesday, its best-ever level. Selling pressure in the afternoon prevented it from achieving another c

Digital coupons business jumps 17% post New York IPOJoins Reddit and Astera Labs as major new listings this yearAt $103.25 day one close, Ibotta market cap over $3 billionThere?s been plenty of talk about an IPO (initial public offering) market revival this year, and Ibotta?s (IBTA:NYSE) blistering New York debut will only bolster that narrative.On its first day as a public company, shares in the

European shares fell on Thursday, with markets grappling with US inflation, Federal Reserve interest rate and geopolitical worries, with the latter hitting travel stocks.Elsewhere among central banks, the European Central Bank left rates unmoved as expected, but the odds of a June cut have risen. The Bank of England is ?way off? cutting, however, a monetary policy committee member said.The FTSE 10

European stocks were in the red on Thursday midday, after hope for Summer interest rate cuts diminished following hotter-than-expected US consumer price inflation.Investors are also eyeing the latest interest rate decision from the European Central Bank and hopes for some clues about the trajectory of rates in a press conference which will follow.The FTSE 100 index was down 18.46 points, 0.2%, at

Annual dividend upped 7% to $3.10Shareholders vote on CEO pay increaseSoriot one of the highest paid FTSE 100 CEOsPharmaceutical giant AstraZeneca (AZN) announced a 7% increase in the annualised dividend to $3.10 per share which the board said, ?underlined the company?s confidence in its performance and cash generation?.Chairman Michel Demare explained that the increase is in line with the firm?s

European equities were mixed on Thursday morning, ahead of the European Central Bank?s next interest rate decision this afternoon.The FTSE 100 index opened up 2.10 points at 7,963.31. The FTSE 250 was down 4.02 points at 19,797.73, and the AIM All-Share was up 1.13 points, 0.2%, at 756.32.The Cboe UK 100 was up 0.1% at 796.00, the Cboe UK 250 was up 0.1% at 17,216.17, and the Cboe Small Companies

Microsoft (MSFT:NASDAQ)-backed cybersecurity firm Rubrik (RBRK:NYSE) plans to raise up to $750 million as it becomes the latest company to unveil plans for an IPO (initial public offering) in the US. The roster of companies planning to go public is starting to fill out after two years of relative drought following recent successes by social media platform Reddit (RDDT:NYSE) and semiconductor conn

THIS IS AN ADVERTISING FEATURE Melissa Gallagher, Head of Investment Trusts, BlackRockFor more than 150 years, the investment trust sector has thrived, surviving wars, financial crises, epidemics and demonstrating a remarkable ability to evolve and remain relevant. UK investment trust assets have increased from £78 billion in 1999, to £267 billion today[1]. Many factors have driven this, but th

Positive late stage trail results for ImfinziFirst and only immunotherapy to demonstrate survival benefitImfinzi is Astra?s second biggest selling cancer drugPharmaceutical giant AstraZeneca (AZN) said a late-stage trial for its blockbuster lung cancer drug Imfinzi significantly improved overall survival and disease-free progression in patients with aggressive small cell lung cancer.Small cell lun

The prospect of a new British ISA has put the spotlight on the UK market. Some investors will not feel comfortable picking individual shares and an alternative is to look at actively managed funds and investment trusts. Here are some tips on putting together a UK-focused portfolio. WHICH FUNDS AND TRUSTS WILL QUALIFY FOR INCLUSION IN THE BRITISH ISA? The rules for which investments can qualify for

The FTSE 100 got a boost in London on Tuesday at midday, thanks to the UK manufacturing sector returning growth in March.The FTSE 100 index was up 23.76 points, 0.3%, at 7,976.38. The FTSE 250 was down 58.37 points, 0.3%, at 19,826.36, and the AIM All-Share was up 0.40 of a point at 743.66.The Cboe UK 100 was up 0.2% at 797.51, the Cboe UK 250 was down 0.7% at 17,220.34, and the Cboe Small Compani

London?s FTSE 100 traded solidly higher at the start of the second quarter, boosted by oil majors and gold miners, ahead of UK data shortly.The FTSE 100 index opened up 48.35 points, 0.6%, at 8,000.97. The FTSE 250 was up 75.55 points, 0.4%, at 19,960.28, and the AIM All-Share was up 3.78 points, 0.5%, at 747.04.The Cboe UK 100 was up 0.5% at 800.00, the Cboe UK 250 was up 0.3% at 17,393.65, and t

In a world of thousands of stocks, certain people just want to focus on ones that are doing well. If these stocks are part of a group with a snappy acronym or label, they must surely matter, right? That is the widespread view among the investment community.Investors love a narrative and what better way to hook people in than with a label that says, ?look at me?. The Magnificent Seven is the latest

The idea behind our investment philosophy is quite simple. We?re living on a planet of around eight billion people ? that planet is finite, and its population is growing but also demanding higher standards of living.The necessary switch to a more sustainable way of running the global economy is being facilitated by new technologies, smart entrepreneurial activity, and government actions to shape n

European stocks went into Monday afternoon in negative territory, with geopolitical tensions putting the brakes on a post-central bank decision rally seen in equities last week.The FTSE 100 index was down 32.76 points, 0.4%, at 7,898.16. The FTSE 250 was down 143.23 points, 0.7%, at 19,581.09, and the AIM All-Share was down 1.03 points, 0.1%, at 738.49.The Cboe UK 100 was down 0.5% at 789.82, the

The FTSE 100 barely budged in early trade in London on Monday, in the aftermath of what was a busy week of central banking action.Rate cut hope spurred on equities last week. The governor of the Bank of England, meanwhile, said rate cuts are ?in play?.Among individual shares, Direct Line and Mobico plunged at the start of the week. Kingfisher declined after softer earnings.The FTSE 100 index opene